| Title |
Glasgow Early Treatment Arm Favirpiravir (GETAFIX) for adults with early stage COVID-19: A structured summary of a study protocol for a randomised controlled trial
|
|---|---|
| Published in |
Trials, November 2020
|
| DOI | 10.1186/s13063-020-04891-1 |
| Pubmed ID | |
| Authors |
Catherine R. Hanna, Kevin G. Blyth, Glenn Burley, Samantha Carmichael, Carol Evans, Samantha Hinsley, Ibrahim Khadra, Saye Khoo, Liz-Anne Lewsley, Robert R. Jones, Raman Sharma, Andrea Taladriz-Sender, Emma C. Thomson, Janet T. Scott |
X Demographics
The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 7 | 78% |
| Unknown | 2 | 22% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 4 | 44% |
| Members of the public | 3 | 33% |
| Scientists | 2 | 22% |
Mendeley readers
The data shown below were compiled from readership statistics for 308 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 308 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 43 | 14% |
| Student > Master | 35 | 11% |
| Researcher | 18 | 6% |
| Student > Ph. D. Student | 17 | 6% |
| Other | 14 | 5% |
| Other | 50 | 16% |
| Unknown | 131 | 43% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 75 | 24% |
| Nursing and Health Professions | 38 | 12% |
| Psychology | 9 | 3% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 2% |
| Social Sciences | 6 | 2% |
| Other | 30 | 10% |
| Unknown | 143 | 46% |